title: Association between glutathione S-transferase M1 null variant and risk of bladder cancer in Chinese Han population.
abstract: Glutathione S-transferase M1 (GSTM1) is one of the most important families of phase II isoenzymes known to detoxify a variety of electrophilic compounds and carcinogens. The GSTM1 null variant is associated with decreased enzyme activity, and it has been assumed to be associated with bladder cancer. The association between the GSTM1 null variant and bladder cancer in the Chinese Han population was unclear owing to the obvious inconsistency from published studies. To quantify the association between the GSTM1 null variant and bladder cancer in the Chinese Han population, we carried out the meta-analysis. We estimated the pooled odds ratio (OR) with its 95% confidence interval (95% CI) to assess the association. Eight studies with a total of 3,887 individuals were finally included into the meta-analysis. Overall, there was an obvious association between the GSTM1 null variant and risk of bladder cancer in the Chinese Han population (OR = 1.61, 95% CI 1.41–1.84, P < 0.001). There was no heterogeneity across those eight studies (I 2 = 0%). The cumulative meta-analyses showed a trend of more obvious association between the GSTM1 null variant and risk of bladder cancer in the Chinese Han population as data accumulated by year. There was no obvious evidence of publication bias in the meta-analysis. In conclusion, the GSTM1 null variant is significantly associated with risk of bladder cancer in the Chinese Han population.
authors.forename: Wei
authors.initials: W
authors.lastname: Xu
authors.forename: Fa
authors.initials: F
authors.lastname: Wang
authors.forename: Li
authors.initials: L
authors.lastname: Ying
authors.forename: Hong-Hui
authors.initials: HH
authors.lastname: Wang
mesh_terms: D044466:Asian People / Q000235:genetics*; D016022:Case-Control Studies; D002681:China; D005787:Gene Frequency; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D005982:Glutathione Transferase / Q000235:genetics*; D006720:Homozygote; D006801:Humans; D016017:Odds Ratio; D017594:Publication Bias; D012306:Risk; D001749:Urinary Bladder Neoplasms / Q000235:genetics*
chemical_list: D005982:Glutathione Transferase
references.citation: Annu Rev Pharmacol Toxicol. 2005;45:51-88
references.pmid: 15822171
references.citation: Cancer. 2008 Jun;112(11):2467-74
references.pmid: 18361427
references.citation: Asian Pac J Cancer Prev. 2011;12(9):2221-6
references.pmid: 22296360
references.citation: CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29
references.pmid: 22237781
references.citation: Pharmacology. 2000 Sep;61(3):154-66
references.pmid: 10971201
references.citation: Mol Biol Rep. 2012 Jan;39(1):685-91
references.pmid: 21553222
references.citation: JAMA. 2008 May 28;299(20):2423-36
references.pmid: 18505952
references.citation: Carcinogenesis. 2004 May;25(5):729-34
references.pmid: 14688016
references.citation: Eur Urol. 2005 Aug;48(2):339-44
references.pmid: 16005379
references.citation: Am J Public Health. 2006 Mar;96(3):515-22
references.pmid: 16449603
references.citation: BMJ. 2003 Sep 6;327(7414):557-60
references.pmid: 12958120
references.citation: J Natl Cancer Inst. 1959 Apr;22(4):719-48
references.pmid: 13655060
references.citation: Control Clin Trials. 1986 Sep;7(3):177-88
references.pmid: 3802833
references.citation: Biomed Environ Sci. 2002 Sep;15(3):253-60
references.pmid: 12500666
references.citation: Eur Urol. 2011 Oct;60(4):721-3
references.pmid: 21840119
references.citation: Annu Rev Pathol. 2009;4:251-85
references.pmid: 18840072
references.citation: Int J Cancer. 2012 Mar 1;130(5):1151-9
references.pmid: 21445976
references.citation: CA Cancer J Clin. 2010 Jul-Aug;60(4):244-72
references.pmid: 20566675
references.citation: Tumour Biol. 2013 Apr;34(2):973-82
references.pmid: 23269608
references.citation: Cancer Detect Prev. 2009;32(5-6):416-23
references.pmid: 19303722
references.citation: Lancet. 2009 Jul 18;374(9685):239-49
references.pmid: 19520422
references.citation: Nat Rev Urol. 2009 May;6(5):281-9
references.pmid: 19424176
references.citation: J Hepatol. 2010 Sep;53(3):508-18
references.pmid: 20561699
references.citation: BMJ. 1997 Sep 13;315(7109):629-34
references.pmid: 9310563
references.citation: Tumour Biol. 2013 Jun;34(3):1651-7
references.pmid: 23483487
references.citation: Int J Urol. 2008 Mar;15(3):216-21
references.pmid: 18304215